Sonnet Biotherapeutics logo

Sonnet Biotherapeutics share price today

(SONN)

Sonnet Biotherapeutics share price is $1.42 & ₹120.98 as on 25 Dec 2024, 2.30 'hrs' IST

$1.42

-0.02

(-1.39%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Sonnet Biotherapeutics share price in Dollar and Rupees. Guide to invest in Sonnet Biotherapeutics from India. Also see the sentimental analysis on Indian investors investing in Sonnet Biotherapeutics. Get details on the Indian mutual funds that are investing in Sonnet Biotherapeutics. Get Analyst recommendations and forecasts along with all the Sonnet Biotherapeutics's financials.

Sonnet Biotherapeutics share price movements

  • Today's Low: $1.41
    Today's High: $1.50

    Day's Volatility :6.0%

  • 52 Weeks Low: $1.41
    52 Weeks High: $18.72

    52 Weeks Volatility :92.47%

Sonnet Biotherapeutics Returns

PeriodSonnet Biotherapeutics Holdings IncIndex (Russel 2000)
3 Months
-75.68%
0.0%
6 Months
-81.29%
0.0%
1 Year
-88.55%
0.0%
3 Years
-99.87%
-21.1%

Sonnet Biotherapeutics Key Statistics

in dollars & INR

Previous Close
$1.44
Open
$1.43
Today's High
$1.5
Today's Low
$1.41
Market Capitalization
$4.3M
Today's Volume
$64.6K
52 Week High
$18.7192
52 Week Low
$1.41
Revenue TTM
$55.9K
EBITDA
$-12.3M
Earnings Per Share (EPS)
$-11.35
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-264.57%

How to invest in Sonnet Biotherapeutics from India?

It is very easy for Indian residents to invest directly in Sonnet Biotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sonnet Biotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sonnet Biotherapeutics or SONN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sonnet Biotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sonnet Biotherapeutics shares which would translate to 0.600 fractional shares of Sonnet Biotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sonnet Biotherapeutics, in just a few clicks!

Returns in Sonnet Biotherapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Sonnet Biotherapeutics investment value today

Current value as on today

₹13,690

Returns

₹86,310

(-86.31%)

Returns from Sonnet Biotherapeutics Stock

₹88,548 (-88.55%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Sonnet Biotherapeutics

1.53%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Sonnet Biotherapeutics from India has grown in the last 30 days as on Dec 26, 2024. 1.53% more purchase transactions for Sonnet Biotherapeutics in the last 30 days versus the previous period.

143%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Sonnet Biotherapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 143% more investors are searching Sonnet Biotherapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Sonnet Biotherapeutics

  • Sabby Management LLC

    3.56%

  • Virtu Financial LLC

    0.49%

  • BlackRock Inc

    0.01%

  • Tower Research Capital LLC

    0.01%

Analyst Recommendation on Sonnet Biotherapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Sonnet Biotherapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Sonnet Biotherapeutics

What analysts predicted

Upside of 11167.61%

Current:

$1.42

Target:

$160.00

Insights on Sonnet Biotherapeutics

  • Price Movement

    In the last 7 days, SONN stock has moved down by -10.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 18.62K → 9.07M (in $), with an average increase of 99.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -3.50M → -3.12M (in $), with an average increase of 12.1% per quarter
  • SONN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 115.4%
  • SONN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 125.1%
  • Price to Sales

    ForSONN every $1 of sales, investors are willing to pay $74.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Sonnet Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Sonnet Biotherapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Sonnet Biotherapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Sonnet Biotherapeutics Holdings Inc
-48.74%
-81.29%
-88.55%
-99.87%
-99.99%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Sonnet Biotherapeutics Holdings Inc
0.25
NA
NA
-12.88
-2.65
-0.97
NA
4.01
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Sonnet Biotherapeutics Holdings Inc
Buy
$4.3M
-99.99%
0.25
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Sonnet Biotherapeutics

sonnet biotherapeutics is an early stage company developing a pipeline of bifunctional therapies that attack immune-modulating targets to control cancer cells. sonnet biotherapeutics is utilizing a platform approach to develop a library of cancer-fighting immunotherapies. sonnet is based in cranbury, new jersey. sonnet mission: sonnet biotherapeutics is a platform enabled proof-of-concept engine created to generate immuno-oncology candidates and develop them into phase ii assets. we are leveraging a unique ip driven platform: ● single chain platform with pk enhancement ● selectively targeting tumors and their micro-environment ● validated targets only ● dual targeting can create synergies
Organization
Sonnet Biotherapeutics
Employees
12
CEO
Dr. Pankaj Mohan Ph.D.
Industry
Consumer Services

Management People of Sonnet Biotherapeutics

NameTitle
Dr. Pankaj Mohan Ph.D.
Founder, Chairman, CEO & President
Dr. John K. Cini Ph.D.
Chief Scientific Officer & Co-Founder
Mr. Jay Cross
Chief Financial Officer
Mr. Donald J. Griffith CPA, CPA
Financial Controller & Director
Dr. Gael Hedou Ph.D.
Chief Operating Officer
Ms. Susan Dexter
Chief Technical Officer
Dr. Richard T. Kenney FACP, M.D.
Chief Medical Officer
Mr. Manuel Dafonseca
Head of Clinical Operations
Dr. Stephen J. McAndrew Ph.D.
Senior Vice President of Business Development

Important FAQs about investing in Sonnet Biotherapeutics from India :

What is Sonnet Biotherapeutics share price today?

Sonnet Biotherapeutics share price today stands at $1.42, Open: $1.43 ; Previous Close: $1.44 ; High: $1.50 ; Low: $1.41 ; 52 Week High: $18.72 ; 52 Week Low: $1.41. The stock opens at $1.43, after a previous close of $1.44. The stock reached a daily high of $1.50 and a low of $1.41, with a 52-week high of $18.72 and a 52-week low of $1.41.

Can Indians buy Sonnet Biotherapeutics shares?

Yes, Indians can invest in the Sonnet Biotherapeutics (SONN) from India.

With INDmoney, you can buy Sonnet Biotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Sonnet Biotherapeutics at zero transaction cost.

How can I buy Sonnet Biotherapeutics shares from India?

It is very easy to buy Sonnet Biotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sonnet Biotherapeutics be purchased?

Yes, you can buy fractional shares of Sonnet Biotherapeutics with INDmoney app.

What are the documents required to start investing in Sonnet Biotherapeutics stocks?

To start investing in Sonnet Biotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Sonnet Biotherapeutics

Today’s highest price of Sonnet Biotherapeutics (SONN) is $1.50.

Today’s lowest price of Sonnet Biotherapeutics (SONN) is $1.41.

What is today's market capitalisation of Sonnet Biotherapeutics

Today's market capitalisation of Sonnet Biotherapeutics SONN is 4.3M

What is the 52 Week High and Low Range of Sonnet Biotherapeutics

  • 52 Week High

    $18.72

  • 52 Week Low

    $1.41

What are the historical returns of Sonnet Biotherapeutics?

  • 1 Month Returns

    -48.74%

  • 3 Months Returns

    -81.29%

  • 1 Year Returns

    -88.55%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Sonnet Biotherapeutics

Dr. Pankaj Mohan Ph.D. is the current Chief Executive Officer (CEO) of Sonnet Biotherapeutics.